Recent advances in CAR-T cell engineeringRuihao Huang, Xi Zhang, Xiaoping Li et al.|Journal of Hematology & Oncology|2020Cited by 403
Mesenchymal Stem Cells for Prophylaxis of Chronic Graft-vs-Host Disease After Haploidentical Hematopoietic Stem Cell TransplantRuihao Huang, Xi Zhang, Peiyan Kong et al.|JAMA Oncology|2023Cited by 53
Off-the-Shelf CD33 CAR-NK Cell Therapy for Relapse/Refractory AML: First-in-Human, Phase I TrialRuihao Huang, Xi Zhang, Qin Wen et al.|Blood|2022Cited by 33
Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-GenzymeLu Wang, Peiyan Kong, Cheng Zhang et al.|Annals of Hematology|2023Cited by 11
Donor-derived CD19 CAR-T Cells versus Chemotherapy Plus Donor Lymphocyte Infusion for Treatment of Recurrent CD19-positive B-ALL After Allogeneic Hematopoietic Stem Cell TransplantationXu Tan, Shifeng Lou, Xiaoqi Wang et al.|Current Medical Science|2023Cited by 8